You are here

thyroid cancer

First Orphan Launch a Challenge for AstraZeneca

PharmExec

Thu, 08/4/11 - 09:55 am

The Good, Bad, and Ugly of Exelixis' Drug Delay

Motley Fool

Thu, 07/7/11 - 10:11 pm

Exelixis Delays Results of Cancer Drug Study

Minyanville

Thu, 07/7/11 - 12:06 pm

AstraZeneca Drug Approved! But Where's the Name?

Motley Fool

Fri, 04/8/11 - 09:35 am

AstraZeneca’s Victory Highlights Difficulty Of Cancer Drug Development

Forbes

Wed, 04/6/11 - 07:46 pm

drug development

Exelixis cancer drug wins 'orphan' tag

Bizjournals.com

Mon, 01/10/11 - 12:35 pm

AstraZeneca: FDA panel says vandetanib could help some medullary thyroid cancer patients

Yahoo/AP

Thu, 12/2/10 - 06:59 pm

Priority Review for AZN Drug

Yahoo/Zacks

Sat, 09/25/10 - 12:14 pm

ZYBRESTAT(TM) (CA4P) Improves Overall Survival in a Phase 2/3 Trial (FACT Study) of Patients With Anaplastic Thyroid Cancer (ATC)

Yahoo/Globe NewsWire

Sun, 09/12/10 - 11:22 am

AstraZeneca reports positive Phase III study

Marketwatch

Mon, 06/7/10 - 09:50 am

Pages